Role of Venom-Induced Consumption Coagulopathy in Assessing the Clinical Severity of Soft-Tissue Inflammation and Prognosis in Snakebite Envenomation: A Prospective Observational Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Aim The study aims to evaluate the correlation between venom-induced coagulation (VIC) markers and the clinical severity of soft-tissue inflammation and injury in snakebite patients, and to determine the predictive value of these markers for prognosis and the need for intensive medical intervention. Setting and design This was a prospective observational study in the emergency department of R.L. Jalappa Hospital and Research Centre, Kolar, Karnataka, South India, over a 12-month period (September 2025-September 2026). Methods and materials One hundred twelve adult patients (≥18 years) presenting within 48 hours of snakebite with localized soft-tissue swelling were enrolled, and soft-tissue involvement was graded as I-IV. Prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (aPTT), fibrinogen, and D-dimer were measured at presentation and repeated at 48 hours, with the endpoint being need for “advanced medical intervention.” Statistical analysis used Statistical analyses included the Mann-Whitney U test, Spearman correlation, and receiver-operating-characteristic (ROC) analysis with bootstrap-corrected Youden index, Firth penalized logistic regression, and Benjamini-Hochberg correction for multiple comparisons. Results Twenty-seven patients (24.1%) had severe local involvement. All five indices differed between the severe and non-severe groups (all q < 0.001), but they did not differ between Grades I and II or between Grades III and IV; the association was therefore categorical, not graded. D-dimer separated the two groups completely (maximum non-severe 1,055 ng/mL; minimum severe 1,520 ng/mL). This complete separation is a feature of this sample, so discrimination for severe local involvement could not be validly estimated, and the resulting area under the curve (AUC) of 1.000 should not be interpreted as predictive performance. Advanced intervention was required in 23 of 104 patients (22.1%). For this endpoint, the AUCs were 0.79-0.83 (INR 0.825, 95% confidence interval (CI) 0.70-0.93; D-dimer 0.822, 95% CI 0.71-0.93), negative predictive values were 89.4%-93.6% (lower 95% confidence limits 81%-86%), and no marker was independently predictive in a multivariable model (7.7 events per variable). Conclusions Baseline coagulation abnormalities were associated with severe local soft-tissue inflammation/injury and, moderately, with the need for advanced intervention. These are observational associations; they do not show that coagulopathy causes local tissue damage, and unmeasured venom burden may explain both. The grading scale is unvalidated, grading was not blinded to laboratory results, inter-rater reliability was not assessed, and the endpoint is a heterogeneous composite based on 23 events. The findings are hypothesis-generating, and external validation is required before any threshold is used clinically.
Source: Cureus
Institution: Sri Devaraj Urs Medical College
Language: English
Subfield: Toxicology
Domain: Life Sciences
Keywords: snakebite, venom-induced coagulopathy, soft tissue inflammation, D-dimer, prothrombin time, activated partial thromboplastin time, fibrinogen, international normalized ratio, clinical severity grading, prognosis, prognostic factors, emergency department management, soft tissue swelling, South India
Open Access status: diamond
OpenAlex ID: W7236826398
